Radiation Necrosis After Gamma Knife: What I Learned, Calmly Explained

Radiation necrosis is a delayed reaction in which treated brain tissue and the area immediately around it become inflamed and damaged, usually in the months after Gamma Knife, and it affects roughly 5 to 25% of people depending mainly on the size of the target and the dose. It is the most important delayed effect of radiosurgery, and it is also the one I understood least when I heard the word. It is not a sign that the treatment has failed¹.

When my follow-up letters started mentioning the possibility of necrosis, I read the word as catastrophe: dead brain, permanent damage, the treatment gone wrong. It took a calm conversation with my team, and a lot of careful reading, to understand that necrosis is a reaction to a dose that is working, that it is often silent, and that when it does cause trouble there are clear ways to treat it. This is the plain account I wish I had read first. For the wider risk picture, see Gamma Knife risks and side effects; for how radiosurgery fits together as a whole, start with the pillar on Gamma Knife radiosurgery.

What is radiation necrosis?

Radiation necrosis is local tissue damage and inflammation that develops where a high radiation dose was delivered, appearing weeks to months after treatment rather than straight away. The same focused dose that stops a tumour growing also acts on the tiny blood vessels and supporting cells nearby, and in some people that reaction goes far enough to cause swelling and breakdown of tissue at the treated site².

It is worth being clear about what it is not. It is not the treatment spreading, and it is not the tumour. It is a reaction confined to the area that was dosed, and it is the price, in a minority of people, of putting a high dose exactly where it needs to go. Radiosurgery delivers that dose gradually in its effect: the target usually stays visible on scans, and control rather than disappearance is the goal³. Necrosis is one of the things that can happen along the way, and the team plans the dose specifically to keep it unlikely.

How common is radiation necrosis?

Radiation necrosis affects roughly 5 to 25% of people after stereotactic radiosurgery, and where an individual sits in that range is driven mainly by the size of the target, usually over 20 mm, and by the dose. A large lesion treated with a high dose sits toward the top of that range; a small one treated with a lower margin dose sits near the bottom¹.

That range mattered to me, because my own case, a small acoustic neuroma treated at a margin dose of 12 to 13 Gy, was at the gentler end of it. I stopped reading “up to 25%” as my personal odds once I understood that the figure covers everything from small nerve tumours to large metastases dosed hard. The point of the planning session, where a neurosurgeon, a radiation oncologist, and a medical physicist work out the dose while you wait, is partly to keep the dose to healthy tissue as low as the target allows. To understand that step, see Gamma Knife planning and dose, and for whether a target is even suitable in the first place, am I a candidate for Gamma Knife.

What does radiation necrosis feel like?

Radiation necrosis often causes no symptoms at all and is found only on a follow-up scan; when it does cause symptoms, they come from local swelling pressing on nearby brain. Because the effect is confined to the treated area, what you notice depends on where that area is: headache and fatigue are common, and there can be more specific effects such as weakness, unsteadiness, or changes in thinking, mirroring the function of the tissue nearby².

For me the honest experience was mostly the fear of it rather than the thing itself. Fatigue after Gamma Knife is common in its own right, and it took some untangling to know what was ordinary tiredness and what, if anything, was worth flagging; I have written about that in fatigue after Gamma Knife. The general rule my team gave me was simple: new or worsening symptoms weeks or months after treatment are worth reporting, not because they mean necrosis, but because they are worth a look.

How is radiation necrosis diagnosed?

Radiation necrosis is diagnosed mainly on MRI, and the difficulty is that it can enlarge and take up contrast in a way that looks like the tumour growing back. This overlap is the crux of the whole subject: an image on its own may not tell necrosis and tumour progression apart, so the team reads it in context, comparing it against earlier scans and sometimes using advanced imaging techniques².

This is exactly why radiosurgery follow-up is built around a schedule of scans rather than a single check. Follow-up is commonly an office visit at about a month, then MRIs at 3, 6, and 12 months, spacing out to every 4 to 6 months after that⁴. Seeing how a treated area behaves over several scans is often what separates a settling necrosis from something that needs acting on. The emotional side of that waiting is real, and I found it harder than the treatment itself: see radiosurgery and scanxiety and, for what the scans are actually looking for, Gamma Knife results and follow-up.

How is radiation necrosis treated?

Radiation necrosis is treated according to how much trouble it causes: mild cases are watched, symptomatic swelling is settled with corticosteroids, and stubborn cases are treated with bevacizumab, with surgery reserved for a minority. Brain swelling from radiosurgery is commonly managed with corticosteroids in the first instance, which reduce the inflammation and its effects⁴. When necrosis does not settle on steroids, bevacizumab, a drug that acts on the leaky blood vessels driving the swelling, is an established next step¹.

What reassured me most was learning that treatment is graded to the problem, not automatic. Many people need nothing beyond continued scans; steroids are a common and effective step; and the harder options exist for the small number who need them. Serious or lasting harm is uncommon, and importantly, treating the necrosis does not undo the control of the target. The two are separate questions.

Why radiation necrosis is not treatment failure

Radiation necrosis is a reaction to a dose that is doing its job, so it is not the same as the treatment failing; control of the target and this side effect can happen in the same person. The whole aim of radiosurgery is control, meaning the target stops growing, and that control unfolds slowly over months to years while the target usually stays visible on scans⁵. You can have that control in full and still develop some necrosis, and treating the necrosis leaves the control intact.

I had to sit with this for a while, because it runs against the instinct that any complication means something has gone wrong. It has not. A working treatment can produce a side effect, and a manageable side effect is not a lost cause. If you are weighing radiosurgery against other paths and want the honest comparison of their risks, see Gamma Knife versus surgery; if you are still deciding whether to treat at all, watch and wait versus Gamma Knife sets out that choice. And if the fear of complications is what is loudest for you right now, you are not alone in that: the emotional side of a brain-tumour diagnosis is the piece I wrote for exactly that feeling.